BOSTON, Jan. 30, 2018 /PRNewswire/ -- Kyros Law
Offices is alerting investors of Valeant Pharmaceuticals Intl
(NYSE:VRX) that it has filed legal claims on behalf of a group of
shareholders against the company for possible securities fraud
violations committed by Valeant Pharmaceuticals Intl
(NYSE:VRX).
The complaint, filed in US District Court for the District of
New Jersey, seeks to get
compensation for a group of investors that have suffered millions
of dollars of losses from investing in VRX stock.
Kyros Law is dedicated to
fighting for the rights of these investors, and other investors
that have lost money in VRX stock.
Valeant Pharmaceuticals Intl (NYSE:VRX) investors that have
invested over $100,000 before
March 2016 are urged to contact our
law firm immediately to protect their rights. Visit our VRX
Lawsuit website or call 1-800-934-2921 to speak to someone
about your case.
The complaint, filed by HUNG G. TA,
ESQ. PLLC, SAFIRSTEIN METCALF LLP, and KYROS LAW, alleges violations of securities law
committed by Valeant Pharmaceuticals Intl (NYSE:VRX) management
that has led to significant losses to investors. According to the
complaint, Valeant Pharmaceuticals Intl (NYSE:VRX) may have
improperly used a pharmacy network to artificially increase sales
for their drugs.
In February 2016, Valeant
Pharmaceuticals Intl (NYSE:VRX) announced it would restate its
financial results, citing issues with revenue recognition stemming
from sales from a specific pharmacy network. That same month, the
company came under SEC investigation. During this time, the stock
price of VRX dropped significantly, with the share prices dropping
more than 90%.
Kyros Law Offices urges Valeant Pharmaceuticals Intl
(NYSE:VRX) investors that invested more than $100,000 prior to March
2016 to contact our law firm immediately to protect their
rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to
find out if you have a case.
Kyros Law specializes in a
wide range of complex litigation, mass torts, and corporate
governance matters, including the representation of whistleblowers,
shareholders and consumers in securities fraud, false claims act
and class actions. Our lawyers have been responsible for recovering
hundreds of millions of dollars for our clients throughout
the United States, Africa, Asia
and Europe. Visit our
website to learn more about our firm.
View original
content:http://www.prnewswire.com/news-releases/vrx-investor-alert-kyros-law-files-legal-claims-on-behalf-of-valeant-pharmaceuticals-intl-nyse-vrx-investors-300590151.html
SOURCE Kyros Law